SCR-LIP-000108 · Claim · machine-readable JSON →

Women with lipedema show better glycemic control (lower HbA1c, higher adiponectin) compared to BMI-matched obese controls, but also exhibit higher LDL-cholesterol, elevated liver enzymes, greater oxidative stress, and a broad pro-inflammatory proteomic profile with 21 upregulated inflammatory proteins, suggesting a mixed rather than uniformly protective metabolic phenotype.

Emerging clinical association Evidence certainty: moderate (GRADE)

Created: 2026-05-31 · Last updated: 2026-05-31

Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-sonnet-4.6 · 2026-05-31

Evidence over time

Is subcutaneous adipose tissue expansion in people living with lipedema healthier and reflected by circulating parameters? — Nankam et al. (2022) — refines · cross sectional · 2022
This cross-sectional study directly compares metabolic and inflammatory biomarkers in lipedema versus BMI-matched obese controls, providing nuanced evidence that partially supports (glycemic protection, higher adiponectin) but also contradi
Adipose Tissue Biology and Effect of Weight Loss in Women With Lipedema — Cifarelli et al. (2025) — supporting · cross sectional · 2025
The study directly compares metabolic health (insulin sensitivity) between women with lipedema (gynoid/peripheral fat distribution) and matched obese controls, finding significantly better insulin sensitivity in the lipedema group, which su

Conditionlipedema

Scopeauto-ingested from Layer 1 surveillance

Auto-ingested single source; not yet human-reviewed.